High Intensity Dysphagia Rehab for Acute Ischemic Stroke Patients
Launched by JOHNS HOPKINS UNIVERSITY · Jul 24, 2023
Trial Information
Current as of July 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study will include adults, aged 18-99, who are admitted to Johns Hopkins Bayview (JHBMC) Rehabilitation Unit following an acute ischemic stroke with a diagnosis of dysphagia, determined by instrumental assessment with a Video Fluoroscopic Swallowing Study (VFSS). All participants will be asked to complete an informed consent form prior to admission to the study. Initial objective assessment of swallowing with video fluoroscopic swallowing assessment will be completed within 72 hours of admission to the unit. Participants with PAS scores of greater than or equal to 3 and FOIS scores of ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Ages 18-99
- • 2. Ischemic Stroke
- • 3. Identified to have acute dysphagia s/p ischemic stroke
- • 4. Able to follow 1-step commands for swallowing directions
- Exclusion Criteria:
- • 1. Younger than 18, older than 100
- • 2. Hemorrhagic Stroke, Subarachnoid hemorrhage, subdural hematoma, epidural hematoma
- • 3. h/o dysphagia
- • 4. Advanced progressive neurological disease
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Alba M Azola, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported